1. Home
  2. TCMD vs HUMA Comparison

TCMD vs HUMA Comparison

Compare TCMD & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCMD
  • HUMA
  • Stock Information
  • Founded
  • TCMD 1995
  • HUMA 2004
  • Country
  • TCMD United States
  • HUMA United States
  • Employees
  • TCMD N/A
  • HUMA N/A
  • Industry
  • TCMD Medical/Dental Instruments
  • HUMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCMD Health Care
  • HUMA Health Care
  • Exchange
  • TCMD Nasdaq
  • HUMA Nasdaq
  • Market Cap
  • TCMD 300.1M
  • HUMA 324.0M
  • IPO Year
  • TCMD 2016
  • HUMA N/A
  • Fundamental
  • Price
  • TCMD $15.06
  • HUMA $1.70
  • Analyst Decision
  • TCMD Buy
  • HUMA Strong Buy
  • Analyst Count
  • TCMD 4
  • HUMA 7
  • Target Price
  • TCMD $16.83
  • HUMA $10.00
  • AVG Volume (30 Days)
  • TCMD 153.0K
  • HUMA 7.6M
  • Earning Date
  • TCMD 11-03-2025
  • HUMA 11-07-2025
  • Dividend Yield
  • TCMD N/A
  • HUMA N/A
  • EPS Growth
  • TCMD N/A
  • HUMA N/A
  • EPS
  • TCMD 0.63
  • HUMA N/A
  • Revenue
  • TCMD $298,851,000.00
  • HUMA $818,000.00
  • Revenue This Year
  • TCMD $8.78
  • HUMA N/A
  • Revenue Next Year
  • TCMD $8.49
  • HUMA $1,686.52
  • P/E Ratio
  • TCMD $24.15
  • HUMA N/A
  • Revenue Growth
  • TCMD 6.15
  • HUMA N/A
  • 52 Week Low
  • TCMD $8.61
  • HUMA $1.15
  • 52 Week High
  • TCMD $21.10
  • HUMA $6.77
  • Technical
  • Relative Strength Index (RSI)
  • TCMD 65.17
  • HUMA 48.54
  • Support Level
  • TCMD $14.44
  • HUMA $1.61
  • Resistance Level
  • TCMD $14.79
  • HUMA $1.90
  • Average True Range (ATR)
  • TCMD 0.36
  • HUMA 0.13
  • MACD
  • TCMD -0.01
  • HUMA -0.01
  • Stochastic Oscillator
  • TCMD 89.32
  • HUMA 35.80

About TCMD Tactile Systems Technology Inc.

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: